New Data Analyses from Phase 3 Study of Investigational Gene Therapy Nadofaragene Firadenovec...

Landmark Study in Non-Muscle Invasive Bladder Cancer Evaluating Breakthrough Investigational Gene...

Gene therapy company focused on uro-oncology continues to expand operations and prepare for the...

The U.S. Food and Drug Administration (FDA) has issued a response to the Biologics License...

Data highlight a need for bladder-sparing therapies to improve outcomes for patients with...

CAMBRIDGE, Mass. - December 19, 2019 FerGene, a new gene therapy company launched by Ferring...